WOCN Society

Abstract Submission Process47th Annual Conference

June 6 – 10, 2015

Times…They are a-changing…

Beginning at the 2015 conference, Continuing Education hours will be available for viewing

posters.VERY EXCITING NEWS!!!

This will require some changes to occur during the

Abstract submission Process.

Please take a few moments to view this information so you can be prepared to submit all the information required.

Author Information

• ALL authors’ names must be “declared” or listed at the time of submission.• Once the abstract is submitted, no other author

names can be added.• Only appropriate VALID and CURRENT credentials for

each author should be usedEXAMPLE:

T. Weedledee BSN, RN, WOCN INCORRECTT. Weedledee BSN, RN, CWOCN CORRECT!!

Author Information: Conflict of Interest

• Every named author must complete the required conflict of interest (COI) form.• In order for the abstract to be considered ready for

review, each author must have their COI submitted by the abstract submission deadline, 12:00PM EST, DECEMBER 30, 2014.• It is the PRIMARY author’s responsibility to inform the

other authors of the requirement to complete the COI. Ultimately the primary author is responsible to make sure the other authors complete the COI document.

CNE Content Integrity• Wound Ostomy and Continence Nurses Society is accredited

as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.• As such, we must ensure that the content of any activity

accredited for continuing nursing education (CNE) adheres to the criteria, standards and policies dictated by the ANCC (and affiliated accrediting entities). • To do so, we must receive information from you to help us

determine if you have a real or potential conflict of interest. • This is outlined by the ANCC by applying the ACCME

Standards for Commercial Support™.

Definitions• The American Nurses Credentialing Center (ANCC) defines an organization

as having a commercial interest (“Commercial Interest Organization”)* if it: • Produces, markets, sells or distributes health care goods or services

consumed by or used on patients; • Is owned or operated, in whole or in part, by an organization that

produces, markets, sells or distributes health care goods or services consumed by or used on patients; or

• Advocates for use of the products or services of commercial interest organizations.

• (*Reference: Accreditation Council for Continuing Medical Education (ACCME) Standards of Commercial Support, August 2007 (www.accme.org) - ANCC’s definition is intended to ensure compliance with Food and Drug Administration Guidance on Industry-Supported Scientific and Educational Activities and consistency with the ACCME definition)

• Relevant relationships, as defined by ANCC, are relationships with a commercial interest if the products or services of the commercial interest are related to the content of the educational activity.

Who must disclose?

• All persons in a position to control or exert influence over the content of a CNE activity MUST disclose to WOCN all relevant relationships with a commercial interest (as defined on the prior page)• The ANCC considers relationships of a spouse,

partner or close family member to be those of the person disclosing. • Any person who does not disclose will be excused

from participation in the CNE portion of the activity.

What information must be disclosed?

• Relationships with any commercial interest of the individual’s spouse/partner may be relevant relationships and must be reported, evaluated, and resolved.

• Evidence of a relevant relationship with a commercial interest may include but is not limited to receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (stock and stock options, excluding diversified mutual funds), grants, contracts, or other financial benefit directly or indirectly from the commercial interest.

• Financial benefits may be associated with employment, management positions, independent contractor relationships, other contractual relationships, consulting, speaking, teaching, membership on an advisory committee or review panel, board membership, and other activities from which remuneration is received or expected from the commercial interest.

• If the research or costs of producing the content to be used in this activity were funded in part or whole by a commercial interest; this includes in-kind donations, travel expenses, production of posters, handouts, etc.

What does WOCN do with the information?

• Information disclosed to WOCN is reviewed to determine if a conflict of interest exists. • The WOCN Lead Nurse Planner (LNP) will work with the

discloser to resolve the conflict, this includes but is not limited to;• limiting the participation of the individual, • peer review of content, • excusing the individual, • not awarding contact hours for the portion of the activity, and;• as otherwise warranted by the WOCN LNP.

• The information is also used to disclose to the audience.

Further Protecting Against Bias

• Generic Names• Use of GENERIC name of products is allowed in the body of the abstract

and in the poster/oral presentations. If mentioned in titles, the GENERIC names of products are to be used.

• Brand names and company names may be identified only once in an acknowledgement section.

• Presentations that constitute promotion and advertising, including pervasive or inappropriate use of logos will not be accepted.

• No company product information may be displayed or disseminated in conjunction with the oral or poster presentation.

• If the cost of a presentation has been underwritten to any extent, a disclosure stating the support and identifying the source will be required at the time of the abstract submission and will be required with the oral or poster presentation (e.g., "The support of [Corporation or Institution] for this project is gratefully acknowledged.").

• Statements should not be viewed as or considered representative of any formal stance or position taken on any subject, issue, or product by the WOCN® Society.

Further Protecting Against Bias

• Company Logos, Slogans or Tag Lines• The logos, slogans or tag lines (or for that matter any marketing or

advertising content) of a commercial interest are not to be used in presentations.

• Further, WOCN strongly advises against the use of any company logos, tag lines or slogans in the content of a presentation, regardless of the company’s status as a commercial interest.

• While the policies are intended to protect against undue influence by commercial interests, WOCN also recognizes that other organizations, not meeting the definition of commercial support may stand to benefit financially by the promotion of their company or products/services and this may create a bias for the planners or faculty who have a relationship with the company.

• The test for this is to ask yourself if the audience members are customer targets of the entity whose logo or materials are to be presented. • If the answer is yes, then WOCN recommends against use. Please

consider this in the development and presentation of your abstract.

Copyrights/Patents & Attribution

• Please provide appropriate symbols and references and secure all permissions if dealing with copyrighted material and/or patents. • This is solely the author(s) responsibility to secure

these permissions. • The WOCN® Society has no responsibility

whatsoever in securing these permissions.• Please give credit to all references used in the

development of the abstract/poster. Oversight of reference may result in abstract/poster rejection.

General Information

• Reminder that abstracts should reflect COMPLETED work, not anticipated work. Incomplete results would be cause for the abstract to be rejected. All work should be completed prior to abstract submission.• The Case Study category requires at least 3 cases,

but could include more. It would be considered RARE, to submit a one case scenario unless it is especially unique, which would be to say that the condition is so very rare, or the solution so groundbreaking that it has not been discussed before, for example.

General Information

• Facility/Company/Personal Names do not belong in the abstract, and would be justification for rejection of the abstract.

Suggestions for Agency:“Small rural hospital in the Midwest”“Level I trauma center in the Northeast USA”“Academic hospital located in the Southwestern

United States”

General Information

• Use appropriate terms—standardization is best• WOC nurse instead of “the CWOCN” or “the WOCN”• WOCN® Society—reflects our legal name

General Information• Product information should be discussed in generic terms

Examples:Moldable ostomy barrier

Silver impregnated foam dressingMulti-layer compression system

Low Frequency UltrasoundNegative Pressure Wound Therapy

Medications: “Ibuprofen” (appropriate) vs “Advil”

• In the “Acknowledgement” Section of your poster, you may clarify these generics, but this section does not appear in the Abstract Submission Process.

General Information

• Before submitting the abstract, ask someone to independently review it for grammar, spelling, and clarity of communication of the information.• Be concise—the abstract is an eagle’s eye overview

of the work. But it is the commercial to make the reader understand what is included and what the topic is about as well.• Do NOT wait until the last minute….anything could

happen….Computer crashes, bad weather, illness, and

LIFE…..begin early!!

General Information

• If you are submitting an abstract, anticipate that it will be accepted, and make arrangements for conference registration early—• The primary author will be expected to register for

the conference upon notification of acceptance of the abstract. There is generally only 30 days after notification to register, so be prepared to do so!! • Registration means that the conference fee is paid,

and this serves as a means to confirm your attendance to present your poster!

General Information

• Posters will be displayed throughout the conference, and the CE poster session will be held on Tuesday of the conference.• Primary authors are expected to be present at their poster

during the CE poster session.• If you are a first time abstract presenter, please indicate that

when asked.• If your abstract focuses on prevention, please indicate that

when asked.• Please note that only research category abstracts will be

considered for oral presentation at the conference. However, even if the information is presented orally, a poster may still be displayed.

General Information

• Specific instructions on posters, including how to cite references, how to acknowledge your agency, how to acknowledge vendor support, how to use logos and so on, will be sent to you if your abstract is accepted for poster presentation.• Oral presentations will be reviewed by the Center

for Clinical Investigation, or the Education Committee/Consultant, and other instructions regarding that process will follow should podium presentation invitation be given.

Good luck with the submission process!!

If you have any questions, please reach out!Dea Kent MSN, RN, NP-C, CWOCN

Abstract CoordinatorNational Conference Planning Committee

deajkent@aol.comTitle your email: Abstract Question

National Office Contacts:Debi Maines

dmaines@wocn.org Brooke Passy

bpassy@wocn.org

References

1. American Nursing Credentialing Center’s Content Integrity Standards (2014). Retrieved from: http://www.nursecredentialing.org/Accreditation/ResourcesServices/Accreditation-CEContentIntegrity